免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

FDA 510(k)

Atellica® CH 高敏C反应蛋白2 (hCRP2)

K号: K233242 · 2024-01-18

决定日期2024-01-18
产品代码NQD
咨询委员会抱歉,您提供的信息不完整,无法进行翻译。请提供完整的医疗设备监管文本,以便我能够进行准确的翻译。
决定实质等同

器械摘要

Atellica® CH High Sensitivity C-Reactive Protein 2 (hCRP2) is the device name listed in this FDA 510(k) record. The listed applicant is Siemens Healthcare Diagnostics, Inc.. It received FDA 510(k) clearance on 2024-01-18 under 510(k) number K233242. The device is classified under product code NQD. It was reviewed by the IM advisory panel. FDA Decision: Substantially Equivalent.

常见问题

What is the Atellica® CH High Sensitivity C-Reactive Protein 2 (hCRP2)?

Atellica® CH High Sensitivity C-Reactive Protein 2 (hCRP2) is a medical device that received FDA 510(k) clearance on 2024-01-18. The listed applicant is Siemens Healthcare Diagnostics, Inc.. The 510(k) number is K233242.

When did Atellica® CH High Sensitivity C-Reactive Protein 2 (hCRP2) receive FDA 510(k) clearance?

Atellica® CH High Sensitivity C-Reactive Protein 2 (hCRP2) received FDA 510(k) clearance on 2024-01-18, under 510(k) number K233242.

Who is the listed applicant for Atellica® CH High Sensitivity C-Reactive Protein 2 (hCRP2)?

FDA 510(k)记录中列出西门子医疗诊断公司(Siemens Healthcare Diagnostics, Inc.)为申请人。这本身并不足以确立该设备制造商的身份。

What is the FDA product code for Atellica® CH High Sensitivity C-Reactive Protein 2 (hCRP2)?

The FDA product code for Atellica® CH High Sensitivity C-Reactive Protein 2 (hCRP2) is NQD.

相关临床试验

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

列明Siemens Healthcare Diagnostics, Inc.为申报人的其他记录

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

查看所有 64 个设备 →

相关器械(代码:NQD)

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

官方来源

在 FDA 数据库中查看 →

数据来源于FDA开放API。如需最新且权威的信息,请务必参考官方记录。

↑